Literature DB >> 19686273

A review of prostate-specific antigen screening prevalence and risk perceptions for first-degree relatives of men with prostate cancer.

M E McDowell1, S Occhipinti, R A Gardiner, P D Baade, S K Steginga.   

Abstract

First-degree relatives of men with prostate cancer have a higher risk of being diagnosed with prostate cancer than men without a family history. The present review examines the prevalence and predictors of testing in first-degree relatives, perceptions of risk, prostate cancer knowledge and psychological consequences of screening. Medline, PsycInfo and Cinahl databases were searched for articles examining risk perceptions or screening practices of first-degree relatives of men with prostate cancer for the period of 1990 to August 2007. Eighteen studies were eligible for inclusion. First-degree relatives participated in prostate-specific antigen (PSA) testing more and perceived their risk of prostate cancer to be higher than men without a family history. Family history factors (e.g. being an unaffected son rather than an unaffected brother) were consistent predictors of PSA testing. Studies were characterized by sampling biases and a lack of longitudinal assessments. Prospective, longitudinal assessments with well-validated and comprehensive measures are needed to identify factors that cue the uptake of screening and from this develop an evidence base for decision support. Men with a family history may benefit from targeted communication about the risks and benefits of prostate cancer testing that responds to the implications of their heightened risk.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19686273     DOI: 10.1111/j.1365-2354.2008.01046.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  14 in total

Review 1.  Inflammation and benign prostatic hyperplasia: clinical implications.

Authors:  Bilal Chughtai; Richard Lee; Alexis Te; Steven Kaplan
Journal:  Curr Urol Rep       Date:  2011-08       Impact factor: 3.092

2.  Latino men and familial risk communication about prostate cancer.

Authors:  Elisabeth M Hicks; Mark S Litwin; Sally L Maliski
Journal:  Oncol Nurs Forum       Date:  2014-09       Impact factor: 2.172

3.  Role of inflammation in benign prostatic hyperplasia.

Authors:  Bilal Chughtai; Richard Lee; Alexis Te; Steven Kaplan
Journal:  Rev Urol       Date:  2011

4.  Effects of a randomized trial comparing standard and enhanced counseling for men at high risk of prostate cancer as a function of race and monitoring style.

Authors:  Pagona Roussi; Suzanne M Miller; Veda N Giri; Elias Obeid; Kuang-Yi Wen; Erin K Tagai; John Scarpato; Laura Gross; Gem Roy
Journal:  J Health Psychol       Date:  2016-10-10

5.  Examining perceived cancer risk among patients with neurofibromatosis type 1.

Authors:  Elyse R Park; Kelly B Smith; Vanessa L Merker; Alona Muzikansky; Ana-Maria Vranceanu; Daphne L Wang; Scott R Plotkin
Journal:  J Neurooncol       Date:  2015-01-06       Impact factor: 4.130

6.  Informed decision making among first-degree relatives of prostate cancer survivors: a pilot randomized trial.

Authors:  Stacy N Davis; Steven K Sutton; Susan T Vadaparampil; Cathy D Meade; Brian M Rivers; Mitul V Patel; Javier F Torres-Roca; Randy V Heysek; Philippe Spiess; Julio Pow-Sang; Paul B Jacobsen; Clement K Gwede
Journal:  Contemp Clin Trials       Date:  2014-10-23       Impact factor: 2.226

7.  Perceptions of Prostate Cancer Screening Controversy and Informed Decision Making: Implications for Development of a Targeted Decision Aid for Unaffected Male First-Degree Relatives.

Authors:  Clement K Gwede; Stacy N Davis; Shaenelle Wilson; Mitul Patel; Susan T Vadaparampil; Cathy D Meade; Brian M Rivers; Daohai Yu; Javier Torres-Roca; Randy Heysek; Philippe E Spiess; Julio Pow-Sang; Paul Jacobsen
Journal:  Am J Health Promot       Date:  2014-06-26

8.  Purposeful interaction: ways Latino men communicate about prostate cancer.

Authors:  Sally L Maliski; Sarah E Connor; Mark S Litwin
Journal:  Oncol Nurs Forum       Date:  2012-11       Impact factor: 2.172

9.  Serum amyloid A, phospholipase A₂-IIA and C-reactive protein as inflammatory biomarkers for prostate diseases.

Authors:  Mario Menschikowski; Albert Hagelgans; Susanne Fuessel; Olga A Mareninova; Liana Asatryan; Manfred P Wirth; Gabriele Siegert
Journal:  Inflamm Res       Date:  2013-09-24       Impact factor: 4.575

10.  Randomized trial of print messaging: the role of the partner and monitoring style in promoting provider discussions about prostate cancer screening among African American men.

Authors:  Suzanne M Miller; Pagona Roussi; John Scarpato; Kuang-Yi Wen; Fang Zhu; Gem Roy
Journal:  Psychooncology       Date:  2013-10-15       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.